CIRIONI, Oscar
 Distribuzione geografica
Continente #
NA - Nord America 8.770
EU - Europa 4.581
AS - Asia 1.093
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 7
OC - Oceania 5
AF - Africa 1
Totale 14.467
Nazione #
US - Stati Uniti d'America 8.745
UA - Ucraina 1.188
IE - Irlanda 681
SE - Svezia 653
IT - Italia 585
TR - Turchia 553
DE - Germania 514
DK - Danimarca 435
FI - Finlandia 249
KR - Corea 231
SG - Singapore 209
GB - Regno Unito 145
FR - Francia 46
CN - Cina 43
IR - Iran 24
CA - Canada 23
BE - Belgio 22
IN - India 21
RU - Federazione Russa 17
NL - Olanda 16
EU - Europa 8
RO - Romania 8
BG - Bulgaria 5
TH - Thailandia 5
AU - Australia 4
CL - Cile 4
PL - Polonia 4
AT - Austria 3
CH - Svizzera 3
JP - Giappone 3
A1 - Anonimo 2
HK - Hong Kong 2
HR - Croazia 2
MX - Messico 2
RS - Serbia 2
AR - Argentina 1
BR - Brasile 1
CI - Costa d'Avorio 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
VE - Venezuela 1
Totale 14.467
Città #
Jacksonville 1.214
Chandler 1.067
Fairfield 840
Dublin 671
Ashburn 505
Wilmington 494
Woodbridge 403
Boardman 353
Ann Arbor 313
New York 309
Houston 302
Seattle 291
Des Moines 290
Lawrence 257
Princeton 257
Cambridge 251
San Mateo 249
San Diego 121
Turin 111
Centro 95
Redmond 59
Beijing 33
London 29
Izmir 28
Norwalk 28
Washington 27
Helsinki 23
Marche 23
Brussels 22
Falls Church 22
Porto 20
Kilburn 15
Ottawa 15
Cingoli 14
Pune 14
Moscow 11
Ancona 10
Rome 10
North Bergen 9
Dronten 8
Prescot 8
Buffalo 7
Chiswick 6
Jesi 6
New Bedfont 6
Pergola 6
Pesaro 6
San Benedetto del Tronto 6
Acton 5
Bangkok 5
Civitanova Marche 5
Los Angeles 5
Amsterdam 4
Auburn Hills 4
Boydton 4
Campobasso 4
Hanover 4
Milan 4
Nanjing 4
Napoli 4
Squinzano 4
Vallefoglia 4
Venice 4
Appignano 3
Breda Di Piave 3
Chiaravalle 3
Dallas 3
Gdansk 3
Guangzhou 3
Hounslow 3
Palermo 3
San Jose 3
Serra 3
Tolentino 3
Toronto 3
Vienna 3
Zurich 3
Adelaide 2
Arco 2
Belgrade 2
Bhopal 2
Birmingham 2
Bologna 2
Cava De' Tirreni 2
Central 2
Fiesole 2
Fort Worth 2
Indore 2
Kagoya 2
La Canada Flintridge 2
Macerata 2
Meppel 2
Monterrey 2
Montréal 2
Mountain View 2
Novara 2
Osimo 2
San Severino Marche 2
Scandicci 2
Simi Valley 2
Totale 9.016
Nome #
Antimicrobial Resistance: A Challenge for the Future 142
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 123
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 109
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 108
Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium 108
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 106
Anticryptosporidial activity of paromomycin. 101
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 97
Characterization of a Multiresistance Plasmid Carrying the optrA and cfr Resistance Genes From an Enterococcus faecium Clinical Isolate 97
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 94
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 92
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 92
Tigecycline accelerates staphylococcal infected burn wound helaing through MMP-9 modlualtion 91
Antimicrobial activity of polycationic peptides 89
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 88
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 87
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 86
null 86
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 83
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 82
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 82
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 81
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 81
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens 80
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 80
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 79
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 79
Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. 78
Epidemiology and microbiology of surgical wound infections. 78
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 78
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 78
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 77
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 76
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 76
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 75
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 74
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum. 74
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 74
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 74
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. 73
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 73
Urinary catheters and biofilm formation 71
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 70
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 70
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 70
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 70
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 70
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 70
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 69
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 68
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 68
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 67
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 67
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 67
Interindividual and intra-individual variabilities of Darunavir and Ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens. 67
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 67
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 67
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 66
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 66
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 66
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 66
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 65
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 65
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 65
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 64
OpuC--an ABC transporter that is associated with Staphylococcus aureus pathogenesis. 64
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. 64
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 64
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 64
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 64
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 64
In- vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii. 64
The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection 64
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in a animal model of ureteral stent infection. 63
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 63
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 63
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 63
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 62
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics. 62
Durability and tolerability of long-term nevirapine-based HAART. 62
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. 62
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 62
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 62
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 62
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 62
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. 61
In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. 61
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes 61
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 61
Review: A safety profile of dalbavancin for onand off-label utilization 61
Efficacy of LL-37 and Granulocyte-Colony Stimulating Factor in a Neutropenic Murine Sepsis due to Pseudomonas aeruginosa 60
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 60
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 60
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 60
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 59
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 59
A In vitro and in vivo activity of aurintricarboxylic acid against Cryptosporidium parvum 59
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 59
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 58
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 58
Totale 7.359
Categoria #
all - tutte 69.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201961 0 0 0 0 0 0 0 0 0 15 1 45
2019/20201.498 13 0 245 7 249 11 254 8 252 54 50 355
2020/20213.635 186 389 497 50 395 233 372 226 367 369 378 173
2021/20222.043 132 450 13 106 33 147 92 118 142 267 133 410
2022/20233.528 350 340 257 251 267 547 7 186 896 18 277 132
2023/20241.763 368 49 135 324 350 419 34 55 22 7 0 0
Totale 14.768